EGETIS THERAPEUTICS AB revenue breakdown overview

EGETIS THERAPEUTICS AB revenue for the last year amounted to 46.10 M SEK, the most of which — 46.10 M SEK — came from its highest performing source at the moment, Emcitate, the year earlier bringing 57.60 M SEK. The greatest contribution to the revenue figure was made by Germany — last year it brought EGETIS THERAPEUTICS AB 29.40 M SEK, and the year before that — 16.90 M SEK.